Key Statistics for CBST
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (USD) (ttm)
|Est. EPS (USD) (12/2013)
|Est. PEG Ratio
|Market Cap (M USD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CBST
- Net Income (M/USD)
Cubist Pharmaceuticals, Inc. is a drug company that discovers, develops, and commercializes novel drugs to treat infections. The Company's lead product is a unique agent with bactericidal activity that addresses the critical need for new antibiotics with potent activity against life threatening infections.
More Company Profile & Key Executives for CBST
|Michael Weston Bonney "Mike"Chief Executive Officer||Robert J Perez "Rob"President/COO|
|Steven C Gilman "Steve"Exec VP:Research & Development||Michael Tomsicek "Mike"Senior VP/CFO|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries